Psilocybin Reduces Fear Memory in Mice With PTSD, Study Shows

A new study published in the Journal of Psychopharmacology demonstrates that psilocybin administration reduces fear-related responses in mice with post-traumatic stress disorder (PTSD). Researchers observed decreased fear memory and increased neuroplasticity markers following psilocybin treatment, suggesting the compound may help rewire trauma-related neural pathways. These preclinical findings provide important evidence for understanding how psychedelics might restore emotional processing in PTSD patients. The study highlights psilocybin's potential as a therapeutic agent for conditions characterized by maladaptive fear memories, opening doors for future clinical research in human populations.